diabetes treatment

  1. I

    Increased Inspections Target Unauthorized GLP-1 Promotion

    New Delhi, April 1 GLP-1-based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity, but they carry serious side effects and must only be taken under the supervision of a qualified medical specialist, the government said on Wednesday.Highlighting that...
  2. A

    Drugmakers Introduce Semaglutide Generics Amid Rising Diabetes Rates

    New Delhi, March 21 Pharmaceutical companies Torrent Pharmaceuticals, Alkem Laboratories, and USV Ltd. launched Semaglutide-based generic diabetes treatment medication in the country on Saturday.Torrent Pharma launched its Semaglutide brands, Sembolic and Semalix, in both oral and injectable...
  3. S

    Increased Access to Diabetes Treatment as Semaglutide Patents Expire

    New Delhi, March 20 Eris Lifesciences launched a generic version of Semaglutide under the brand name 'Sundae' in the country on Friday, capitalizing on the expiration of patents for molecules similar to Ozempic and Wegovy in India.The company stated that it is introducing the diabetes and...
  4. S

    Zydus and Torrent Pharma Partner on Semaglutide Injection

    New Delhi, March 18 Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement to co-market the diabetes treatment medication Semaglutide Injection in the Indian market.Under the terms of the agreement, Zydus will manufacture and supply the product, while...
  5. A

    Ozempic & Mounjaro Counterfeits: Risks and Availability

    New Delhi, March 17 Fake and falsified obesity drugs could be prompting a public health concern driven by high prices, a lack of insurance, and the desire to lose weight, according to a world report article published in The Lancet journal.Author Sophie Cousins, an Australian writer and health...
  6. G

    Zydus and Lupin Partner to Expand Diabetes Treatment Access

    New Delhi, March 17 Zydus Lifesciences announced on Tuesday that it has entered into a licensing and supply agreement with Lupin to expand access to the diabetes treatment drug Semaglutide Injection (15 mg/3 ml) with a patient-friendly, reusable pen device in India.The agreement aims to...
  7. A

    Affordable Medicines Reach Jamtara Residents Through Jan Aushadhi Kendra

    Jamtara, March 7 – With the launch of the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), a ambitious public welfare initiative by the Narendra Modi government, the Jan Aushadhi Kendra located near Veer Kunwar Chowk in the Jamtara district of Jharkhand, is rapidly becoming a major...
  8. A

    Generic Medicines Accessible Through New Healthcare Hub

    Bhopal, February 15 – The Jan Aushadhi Kendra, established in the Rajgarh district of Madhya Pradesh, has become a new hub of activity, as patients and their relatives are flocking to the medical store to purchase highly subsidized medicines, which elsewhere are a significant financial burden...
  9. A

    OneSource & Hikma Secure Ozempic Commercialization in Saudi Arabia

    New Delhi, February 11 OneSource Speciality Pharma announced on Wednesday that, along with Hikma, it has received approval from the Saudi Food and Drug Authority for a generic version of the diabetes and weight reduction medication Ozempic.The company has partnered with Hikma Pharmaceuticals...
Back
Top